JP2012520084A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012520084A5 JP2012520084A5 JP2011554266A JP2011554266A JP2012520084A5 JP 2012520084 A5 JP2012520084 A5 JP 2012520084A5 JP 2011554266 A JP2011554266 A JP 2011554266A JP 2011554266 A JP2011554266 A JP 2011554266A JP 2012520084 A5 JP2012520084 A5 JP 2012520084A5
- Authority
- JP
- Japan
- Prior art keywords
- vector
- virus
- protein
- present
- heterologous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16028509P | 2009-03-13 | 2009-03-13 | |
| US61/160,285 | 2009-03-13 | ||
| US16676909P | 2009-04-05 | 2009-04-05 | |
| US61/166,769 | 2009-04-05 | ||
| US16708809P | 2009-04-06 | 2009-04-06 | |
| US61/167,088 | 2009-04-06 | ||
| PCT/US2010/027262 WO2010105251A2 (en) | 2009-03-13 | 2010-03-13 | Non-integrating retroviral vector vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012520084A JP2012520084A (ja) | 2012-09-06 |
| JP2012520084A5 true JP2012520084A5 (https=) | 2013-04-25 |
Family
ID=42729161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011554266A Withdrawn JP2012520084A (ja) | 2009-03-13 | 2010-03-13 | 非組み込み型レトロウイルスベクターワクチン |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20120135034A1 (https=) |
| EP (1) | EP2405945A4 (https=) |
| JP (1) | JP2012520084A (https=) |
| CN (1) | CN102438658A (https=) |
| CA (1) | CA2754603A1 (https=) |
| RU (1) | RU2012140691A (https=) |
| WO (1) | WO2010105251A2 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130302368A1 (en) * | 2011-01-27 | 2013-11-14 | Boro Dropulic | Advanced Prime and Boost Vaccine |
| RU2014100160A (ru) * | 2011-06-10 | 2015-07-20 | Блуберд Байо, Инк. | Векторы генной терапии адренолейкодистрофии и адреномиелонейропатии |
| PT2831095T (pt) * | 2012-03-30 | 2019-01-30 | Immune Design Corp | Partículas de vectores lentivirais com melhor eficácia de transdução de células que expressam dc-sign |
| US9713635B2 (en) * | 2012-03-30 | 2017-07-25 | Immune Design Corp. | Materials and methods for producing improved lentiviral vector particles |
| ES2745103T3 (es) * | 2013-06-15 | 2020-02-27 | Tocagen Inc | Partículas inmunosupresivas similares a virus basadas en gammaretrovirus |
| EP2878674A1 (en) * | 2013-11-28 | 2015-06-03 | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) | Stable episomes based on non-integrative lentiviral vectors |
| CA2945816A1 (en) | 2014-04-15 | 2015-10-22 | University Of Virginia Patent Foundation | Isolated t cell receptors and methods of use therefor |
| JP2018510160A (ja) * | 2015-03-20 | 2018-04-12 | ブルーバード バイオ， インコーポレイテッド | ベクター製剤 |
| MA41382A (fr) * | 2015-03-20 | 2017-11-28 | Univ Temple | Édition génique basée sur le système crispr/endonucléase à induction par tat |
| WO2017066570A1 (en) * | 2015-10-15 | 2017-04-20 | The University Of North Carolina At Chapel Hill | Methods and compositions for integration-defective lentiviral vectors |
| WO2017156170A1 (en) * | 2016-03-09 | 2017-09-14 | University Of Massachusetts | Use of modified hiv-1 for generating fully human antibodies |
| GB201715052D0 (en) * | 2017-09-19 | 2017-11-01 | Oxford Genetics Ltd | Vectors |
| WO2019112921A1 (en) | 2017-12-07 | 2019-06-13 | Merck Sharp & Dohme Corp. | Formulations of dengue virus vaccine compositions |
| RU2681482C1 (ru) * | 2018-02-13 | 2019-03-06 | Общество с ограниченной ответственностью "Нанолек" | MDCK клетка-продуцент белков вируса гриппа (варианты) |
| RU2680703C1 (ru) * | 2018-02-13 | 2019-02-25 | Общество с ограниченной ответственностью "Нанолек" | Кассета, предназначенная для получения плазмидных векторов, используемых для создания клеток-продуцентов вирусоподобных частиц (ВПЧ) вируса гриппа |
| RU2681439C1 (ru) * | 2018-02-13 | 2019-03-06 | Общество с ограниченной ответственностью "Нанолек" | Вирусоподобная частица вируса гриппа и способ ее получения |
| RU2680537C1 (ru) * | 2018-02-13 | 2019-02-22 | Общество с ограниченной ответственностью "Нанолек" | Лентивирусная плазмида (варианты), способ ее получения (варианты), набор праймеров для получения лентивирусного плазмидного вектора (варианты) |
| US20220275043A1 (en) | 2018-07-17 | 2022-09-01 | Massachusetts Institute Of Technology | Soluble multimeric immunoglobulin-scaffold based fusion proteins and uses thereof |
| AU2019387218A1 (en) | 2018-11-26 | 2021-06-03 | Massachusetts Institute Of Technology | Compositions and methods for immune tolerance |
| WO2020252455A1 (en) | 2019-06-13 | 2020-12-17 | The General Hospital Corporation | Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells |
| EP4185600A4 (en) | 2020-07-24 | 2024-12-04 | The General Hospital Corporation | Enhanced virus-like particles and methods of use thereof for delivery to cells |
| AU2022377374A1 (en) * | 2021-10-25 | 2024-05-02 | Genvivo, Inc. | Compositions and methods for therapeutic or vaccine delivery |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2286819A1 (en) * | 1997-04-17 | 1998-10-22 | Flossie Wong-Staal | Use of lentiviral vectors for antigen presentation in dendritic cells |
| US5994136A (en) * | 1997-12-12 | 1999-11-30 | Cell Genesys, Inc. | Method and means for producing high titer, safe, recombinant lentivirus vectors |
| US7514233B2 (en) * | 2002-09-26 | 2009-04-07 | K.U. Leuven Research & Development | Integrase cofactor |
| GB0225786D0 (en) * | 2002-11-05 | 2002-12-11 | Glaxo Group Ltd | Vaccine |
| US20050196381A1 (en) * | 2003-09-09 | 2005-09-08 | Xiaobin Lu | Lentivirus vector-based approaches for generating an immune response to HIV in humans |
| ES2388527T3 (es) * | 2003-09-15 | 2012-10-16 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Vacunas de VIH basadas en Env de múltiples clados de VIH |
| FR2872170B1 (fr) * | 2004-06-25 | 2006-11-10 | Centre Nat Rech Scient Cnrse | Lentivirus non interactif et non replicatif, preparation et utilisations |
| AU2005309485A1 (en) * | 2004-11-24 | 2006-06-01 | Nanovector Limited | Viral vectors |
| AU2006214278C1 (en) * | 2005-02-16 | 2012-07-19 | Miltenyi Biotec Technology, Inc. | Lentiviral vectors and their use |
| GB0526211D0 (en) * | 2005-12-22 | 2006-02-01 | Oxford Biomedica Ltd | Viral vectors |
| PL2020444T3 (pl) * | 2007-08-03 | 2017-10-31 | Pasteur Institut | Wadliwe nieintegrujące lentiwirusowe wektory przenoszące dla szczepionek |
-
2010
- 2010-03-13 JP JP2011554266A patent/JP2012520084A/ja not_active Withdrawn
- 2010-03-13 US US13/256,216 patent/US20120135034A1/en not_active Abandoned
- 2010-03-13 CA CA2754603A patent/CA2754603A1/en not_active Abandoned
- 2010-03-13 WO PCT/US2010/027262 patent/WO2010105251A2/en not_active Ceased
- 2010-03-13 RU RU2012140691/10A patent/RU2012140691A/ru not_active Application Discontinuation
- 2010-03-13 EP EP10751533A patent/EP2405945A4/en not_active Withdrawn
- 2010-03-13 CN CN2010800204988A patent/CN102438658A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012520084A5 (https=) | ||
| US20120135034A1 (en) | Non-Integrating Retroviral Vector Vaccines | |
| CN110958887B (zh) | 编码hiv抗原的痘病毒载体及其使用方法 | |
| JP2018076363A (ja) | レンチウイルス遺伝子導入ベクター及びそれらの医薬品への適用 | |
| JP2013027396A (ja) | クレードＡ／Ｇ、クレードＢ、およびクレードＣ改変ＨＩＶｅｎｖ、ｇａｇ、およびｐｏｌ遺伝子を発現する組換えＭＶＡウイルス | |
| Di Nunzio et al. | HIV-derived vectors for therapy and vaccination against HIV | |
| US20110142880A1 (en) | Lentivirus-based immunogenic vectors | |
| CN104039968B (zh) | 非b亚型gag蛋白在慢病毒包装中的应用 | |
| JP2024502658A (ja) | 麻疹－ｈｉｖ又は麻疹－ｈｔｌｖワクチン | |
| CA2825032A1 (en) | Advanced prime and boost vaccine | |
| EP1543837A1 (en) | Virus-like particle (VLP) as vaccine | |
| RU2697781C2 (ru) | Вспомогательный плазмидный лентивирусный экспрессионный вектор для получения высоких титров vpx-содержащих лентивирусных частиц, обеспечивающий эффективное заражение моноцитов и дендритных клеток человека | |
| Wang et al. | Polyvalent DNA prime and envelope protein boost HIV‐1 vaccine elicits humoral and cellular responses and controls... | |
| McKenna | Characterization and immunogenicity of recombinant rhabdoviral vaccine vectors expressing HIV-1 and SIV envelope proteins | |
| HK1200870B (en) | Use of non-subtype b gag proteins for lentiviral packaging |